Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Stem Cell Res. 2018 Dec 5;34:101362. doi: 10.1016/j.scr.2018.101362

Resource table

Unique stem cell line identifier TRNDi002-B
Alternative name(s) of stem cell line HT519B
Institution National Institutes of Health, National Center for Advancing Translational Sciences, Bethesda, Maryland, USA
Contact information of distributor Dr. Wei Zheng, Wei.Zheng@nih.gov
Type of cell line iPSC
Origin Human
Additional origin info Age: 10-year-old
Sex: Male
Ethnicity: Caucasian
Cell Source Skin fibroblasts
Clonality Clonal
Method of reprogramming Integration-free Sendai viral vectors
Genetic modification NO
Type of modification N/A
Associated disease NGLY1 Deficiency
Gene/locus NGLY1Q208X; NGLY1G310G
Method of modification N/A
Name of transgene or resistance N/A
Inducible/constitutive system N/A
Date archived/stock date 04-27-2018
Cell line repository/bank Human Pluripotent Stem Cell Registry https://hpscreg.eu/cell-line/TRNDi002-B
Ethical approval NIGMS Informed Consent Form was obtained from patient at time of sample submission. Confidentiality Certificate: CC-GM-15-004